Envita Medical Centers Triumphs Over Precision Oncology Barriers, Pioneering Life-Saving Solutions
Scottsdale, Arizona (PRWEB) May 17, 2023 -- Precision oncology has begun to revolutionize cancer treatment outcomes and will continue to accelerate powerful changes in oncology over the next 5 years. According to internal data analysis of patient outcomes*, Envita's patients treated with precision detailed informatics, including genomic, transcriptomic, and immunotherapy approaches, have reported an impressive 88% improvement in symptoms with 95% fewer side effects. Furthermore, a staggering 90% of patients had been receiving the wrong treatment prior to seeking care at Envita.
Envita's board-certified and multi-disciplinary physicians are dedicated to providing comprehensive medical care in compliance with state and federal laws. Our team comprises MDs and DOs specializing in medical oncology, infectious disease, psychiatry, pediatrics, internal medicine, diagnostic and procedural interventional radiology, as well as homeopathic and integrative doctors licensed under the MD(h) and DO(h) licensure in the state of Arizona. We also have licensed naturopathic physicians and pharmacists as part of our expert team. All our physicians and staff are required to undergo 1500 hours (approximately one year) of training to ensure their expertise and competence.
Dr. Dino Prato, CEO and Founder of Envita Medical Centers, expressed, "Envita has established the necessary infrastructure to evaluate and implement evidence-based solutions for precision and regenerative medicine. We have overcome numerous obstacles that patients often face when seeking precision oncology, including insurance reimbursement, medication procurement, staff training, institutional bias, and policies." Dr. Prato further added, "To the best of our knowledge, there is no other treatment facility offering the same comprehensive range of advanced integrative treatments and diverse physician licenses under one roof. This allows us to provide truly unified, seamless, safe, and effective integrative care, as opposed to the fragmented and disjointed care patients often receive from various facilities. These innovations are particularly crucial for patients who have been unsuccessful in their previous treatment endeavors."
According to studies, less than 20% of cancer patients have access to precision care (Strickler, J., & Sison, E. A. R. (2022, January 27). Duke Molecular Tumor Board: Tackling barriers to precision cancer medicine. Medscape. Retrieved February 23, 2023, from https://www.medscape.org/viewarticle/966786) . Precision oncology transcends standard biopsy histology by incorporating genomic, transcriptomic, immunotherapy, and molecular data. This approach enables the development of highly personalized treatment options that target the unique cancer hallmarks of each patient. At Envita, we firmly believe that there is no "one-size-fits-all" treatment for cancer. Our individualized approach to medical care is of paramount importance to our patients. In our clinical opinion, when a treatment does not align with a patient's genetic and other targets, it not only wastes valuable time but also hampers treatment outcomes significantly—especially for late-stage cancer patients.
Dr. Prato shared his vision, stating, "Our mission is to help eradicate cancer through forward-thinking personalized medicine. We are committed to making this care accessible to as many patients as possible." He emphasized Envita's commitment to transparency, stating, "We provide detailed and itemized costs upfront, enabling patients and their families to make informed decisions regarding their care. We never pressure patients into treatment; instead, we support them in making the best decisions for themselves and their families."
Highlighting the success of Envita's approach, Dr. Prato emphasized, "We are thrilled to witness our patients' improved quality of life and response rates, as reflected in both our clinical results and patient testimonials. The majority of our patients come to us through word-of-mouth referrals, underscoring the level of precision care Envita provides."
*Data is based on our analysis of records for 87 out of 129 patients that participated in Envita’s treatment program in 2020. 42 patients were removed from the cohort due the patient’s inability to start or complete Envita’s prescribed treatment for a variety of reasons, including but not limited to, advanced disease state, disease progression, or inability to travel.
About Envita Medical Centers and Envita Center of Excellence (COE)
Envita Medical Centers and Envita COE, located in Scottsdale, Arizona, is one of the largest Integrative Health institutions in the world with campuses totaling 100,000 sq. Ft. This Center of Excellence provides precision genomic targeted care along with advanced immunotherapies to focus on treating the causative factors in cancer and chronic diseases for a holistic recovery. This unique integrative model, coupled with their in-house minimally invasive surgical team and custom compounded pharmacy division, has placed Envita on the global map of leaders in modern medicine. To learn more about Envita Medical Centers visit https://www.envita.com/
Eric Hoefer, Envita Medical Centers, https://www.envita.com/, 1 4807956688, [email protected]
Share this article